The news releases are issued by FUJIFILM Corporation in Japan.
Fujifilm makes no representation that products on these news releases are commercially available in all countries and regions.
Please note that contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.
- Dec 20, 2022
- Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
- Oct 6, 2022
- Fujifilm to establish its first Bio-CDMO site in Japan
- Jun 29, 2021
- $850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity